By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – OncoVista Innovative Therapies announced that it has sold its majority stake in tumor diagnostics subsidiary AdnaGen to an entity called Alere Holdings Bermuda Limited Canon's Court.
Registering provides access to this and other free content.
Already have an account?Login Now.
The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.
Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.
Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.
In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.